- Home
- CCU vs SLNO Comparison
CCU vs SLNO Comparison
Compare CCU & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- SLNO
- Stock Information
- Founded
- CCU 1850
- SLNO 1999
- Country
- CCU Chile
- SLNO United States
- Employees
- CCU N/A
- SLNO N/A
- Industry
- CCU Beverages (Production/Distribution)
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CCU Consumer Staples
- SLNO Health Care
- Exchange
- CCU Nasdaq
- SLNO Nasdaq
- Market Cap
- CCU 2.3B
- SLNO 2.2B
- IPO Year
- CCU 1992
- SLNO 2014
- Fundamental
- Price
- CCU $12.96
- SLNO $46.13
- Analyst Decision
- CCU Strong Sell
- SLNO Strong Buy
- Analyst Count
- CCU 2
- SLNO 5
- Target Price
- CCU $9.70
- SLNO $71.20
- AVG Volume (30 Days)
- CCU 114.4K
- SLNO 400.5K
- Earning Date
- CCU 02-25-2025
- SLNO 03-05-2025
- Dividend Yield
- CCU 3.23%
- SLNO N/A
- EPS Growth
- CCU 16.02
- SLNO N/A
- EPS
- CCU 0.39
- SLNO N/A
- Revenue
- CCU $2,795,960,314.00
- SLNO N/A
- Revenue This Year
- CCU $8.10
- SLNO N/A
- Revenue Next Year
- CCU $6.92
- SLNO N/A
- P/E Ratio
- CCU $16.86
- SLNO N/A
- Revenue Growth
- CCU N/A
- SLNO N/A
- 52 Week Low
- CCU $10.00
- SLNO $36.61
- 52 Week High
- CCU $13.74
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- CCU 66.34
- SLNO 40.51
- Support Level
- CCU $12.57
- SLNO $48.48
- Resistance Level
- CCU $13.08
- SLNO $52.46
- Average True Range (ATR)
- CCU 0.24
- SLNO 2.07
- MACD
- CCU 0.02
- SLNO -0.47
- Stochastic Oscillator
- CCU 86.67
- SLNO 0.94
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.